久久午夜影院,国产大鸡巴九色,丰满人妻一区=区三区在线视频53,五月天婷婷激情四射在线观看

    <source id="7npa8"><tr id="7npa8"><dfn id="7npa8"></dfn></tr></source>
    1. 產(chǎn)品中心您現(xiàn)在的位置:首頁(yè) > 產(chǎn)品展示 > > 蛋白&肽 > Ubiquitin activating enzyme E1 (human), (recombina

      Ubiquitin activating enzyme E1 (human), (recombina

      更新時(shí)間:2022-01-28

      簡(jiǎn)要描述:

      Ubiquitin activating enzyme E1 is responsible for the first step in ubiquitin-protein isopeptide bond formation and is a critical component for the initiation of in vitro conjugation reactions. E1 ……

      型號(hào):廠商性質(zhì):代理商瀏覽量:948
      Ubiquitin activating enzyme E1 is responsible for the first step in ubiquitin-protein isopeptide bond formation and is a critical component for the initiation of in vitro conjugation reactions. E1 activates ubiquitin by first adenylating with ATP the C-terminal glycine carboxyl group of ubiquitin and, thereafter, linking this residue to the sulphydryl side chain moiety of a cysteine residue in E1 by forming a high energy thiol ester bond and liberating free AMP. There are two active sites within the E1 molecule allowing it to accommodate two ubiquitin molecules at one time, with a new ubiquitin forming an adenylate intermediate as the previous one is transferred to the thiol site. The activated ubiquitin is then transferred to the lysine of target proteins via the E2/E3 conjugation cascade.


      Product Details

      MW:118 kDa

      Source:Produced in E. coli BL21 (λDE3) expression system and containing a C-terminal His6-tag. Full length human ubiquitin-activating enzyme E1.

      UniProt ID:P22314

      Formulation:Liquid. In 50mM TRIS-HCl, pH 7.5, containing 1.0mM DTT.

      Purity:≥90% (SDS-PAGE)

      Purity Detail:Purified by multi-step chromatography.

      Shipping:Shipped on Dry Ice

      Long Term Storage:-80°C

      Handling:Avoid freeze/thaw cycles.

      Scientific Background:Results demonstrate the formation of ubiquitin thioester linked E2 conjugates of the expected size in all TE +ve control reactions. The absence of such conjugates in TE –ve control reactions demonstrates that their formation is ATP dependent (required for E1 activation) and hence derived from the ubiquitin cascade.

      Regulatory Status:RUO - Research Use Only

      <strong>Ubiquitin activating enzyme E1 (human), (recombinant) (His-tag)</strong> Western blot

      Figure A: Product purity determined by Coomassie staining following SDS-PAGE

      Figure B: Western Blot of thioester assays (TE +ve/-ve controls) for E2 conjugating enzymes. Biotinylated-ubiquitin-enzyme conjugates were detected by western blotting on thioester assays containing: A: UbcH2 (Prod. No. BML-KW9025), B: UbcH8 (KW9135), respectively, using Streptavidin-HRP detection system. M: Biotinylated SDS molecular weight markers (Sigma, SDS-6B) from bottom: 20.1, 29.0, 39.8, 58.1kDa.

      Please mouse over
      <strong>Ubiquitin activating enzyme E1 (human), (recombinant) (His-tag)</strong> Western blot


      Product Literature References

      CD95/Fas suppresses NF-kB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism: J.P. Guégan, et al.; iScience 24, 103538 (2021), Abstract;
      CD95/Fas suppresses NF-kB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism: J.P. Guégan, et al.; iScience 24, 103538 (2021), Abstract;
      The cooperative action of CSB, CSA, and UVSSA target TFIIH to DNA damage-stalled RNA polymerase II: Y. Weegen, et al.; Nat. Commun. 11, 2104 (2020), Abstract; Full Text
      ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer: K. Li, et al.; Cell Res. 30, 163 (2019), Abstract; Full Text
      Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC): F. Aguilar-Alonso, et al.; Bioorg. Med. Chem. 26, 1179 (2018), Abstract;
      BLM Potentiates c-Jun Degradation and Alters Its Function as an Oncogenic Transcription Factor: R. Priyadarshini, et al.; Cell Rep. 24, 947 (2018), Abstract;
      Role of ubiquitylation of components of mitotic checkpoint complex in their dissociation from anaphase-promoting complex/cyclosome: D. Sitry-Shevah, et al.; PNAS 115, 1777 (2018), Abstract; Full Text
      Modulating cellular balance of Rps3 mono-ubiquitination by both Hel2 E3 ligase and Ubp3 deubiquitinase regulates protein quality control: Y. Jung, et al.; Exp. Mol. Med. 49, e390 (2017), Abstract; Full Text
      The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover: R. Tawo, et al.; Cell 169, 470 (2017), Abstract; Full Text
      Monoubiquitination Inhibits the Actin Bundling Activity of Fascin: S. Lin, et al.; J. Biol. Chem. 291, 27323 (2016), Abstract; Full Text
      Regulation of the Abundance of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2: T.H. Chang, et al.; PLoS Pathog. 12, e1005918 (2016), Abstract; Full Text
      F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7: Y. Liu, et al.; Cell Death Dis. 6, e1630 (2015), Application(s): Assay, Abstract; Full Text
      Pro-apoptotic F-box protein Fbxl7 regulates mitochondrial function by mediating the ubiquitylation and proteasomal degradation of survivin: Y. Liu, et al.; J. Biol. Chem. 290, 11843 (2015), Application(s): Assay, Abstract; Full Text
      UBXN2A regulates nicotinic receptor degradation by modulating the E3 ligase activity of CHIP: Y. Teng, et al.; Biochem. Pharmacol. 97, 518 (2015), Application(s): Western Blot, Abstract;
      ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation: S. Wakatsuki, et al.; Nat. Cell Biol. 13, 1415 (2011), Abstract;
      Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation: A. L. Haas, et al.; J. Biol. Chem. 257, 2543 (1982), Abstract;
      Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system: A. L. Cienchanover; PNAS 78, 761 (1981), Abstract;


      留言框

      • 產(chǎn)品:

      • 您的單位:

      • 您的姓名:

      • 聯(lián)系電話:

      • 常用郵箱:

      • 省份:

      • 詳細(xì)地址:

      • 補(bǔ)充說(shuō)明:

      • 驗(yàn)證碼:

        請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7